Population Adult (high risk) patients with deteriorated mitral bioprosthesis Intervention Transcatheter, transapical mitral valve-in-valve implantation Control  Mitral

To date, five transcatheter mitral valve systems have been implanted in humans: CardiAQ valve system (CardiAQ Valve Technologies, Inc.); Tiara™ valve (Neovasc Inc.,

COMMONS-IO - commons io 1.4 The Apache Software License, Version 2.0 COMMONS-IO - io 1.1 The Apache Software License, Version 2.0 COMMONS-IO - io 1.2 The Apache

Aortic valve replacement, surgical Aortic valve replacement, transcatheter Mitral valve balloon valvotomy/valvuloplasty Mitral valve commissurotomy, surgical Mitral valve

Percutaneous transvenous trans- septal transcatheter valve implantation in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification. Yoon

The evidence for or the use of MitraClip® in patients with severe symptomatic degenerative mitral regurgitation (DMR) or functional mitral regurgitation (FMR) who are considered

Fujita T, Saito N, Minakata K, Imai M, Yamazaki K, Kimura T (2017) Transfemoral transcatheter aortic valve implantation in the presence of a mechanical mitral valve prosthesis using

Integrated imaging of echocardiography and computed tomography to grade mitral regurgitation severity in patients undergoing transcatheter aortic valve implantation.. van Rosendael

Keywords: Transcatheter aortic valve implantation durability (TAVI durability); aortic stenosis; structural valve deterioration; long-term outcomes; valve hemodynamics.. Submitted

posed that groups the devices into those targeting the leaflets (percutaneous leaflet plication, percuta- neous leaflet coaptation, percutaneous leaflet ablation), the annulus

Transcatheter VIV procedures will likely increasingly be favoured over reoperation when bioprosthetic heart valves fail, particularly when surgical risks are high..

Indication: The MitraClip Clip Delivery System is indicated for the percutaneous reduction of significant symptomatic mitral regurgitation (MR ≥ 3+) due to primary abnormality of

(VinV) implantation for failed mitral xenografts using a minimally invasive, transatrial, off-pump approach.. Methods

This review will focus on long-term surgical outcomes of mitral valve repair with artificial chordae and on the emerging transcatheter chordal repair devices as therapeutic options

Keywords: Aortic stenosis; transcatheter aortic valve replacement (TAVR); transcatheter aortic valve implantation; cerebrovascular events (CVEs); cerebral protection devices

The latest results of the early feasibility study of the Neovasc Tiara™ mitral transcatheter heart valve system (TIARA-I) and the Tiara™ Transcatheter Mitral Valve Replacement

Meta-analysis of mortality outcomes and mitral regurgitation evolution in 4,839 patients having transcatheter aortic valve implantation for severe aortic stenosis. D ’ Onofrio

Case reports and case series presented preliminary experience of implantation of transcatheter aortic valve replacement devices in patients with severe mitral annular calcifi